Table 2.
Frequency and proportion ofthe 211 men inthe P3P intervention andcontrol group who madea concordant treatment choiceby 6-months given theirconcerns about influential sideeffects (bladder, sex, andbowel) at enrollment
|
Influential Side Effects |
Overall |
Active surveillance |
External Beam Radiotherapy |
Brachytherapy |
Radical Prostatectomy |
|||||
|---|---|---|---|---|---|---|---|---|---|---|
| |
Intervention N = 107 |
Control N = 104 |
Intervention N = 15 |
Control N = 24 |
Intervention N = 15 |
Control N = 13 |
Intervention N = 16 |
Control N = 7 |
Intervention N = 61 |
Control N = 60 |
| N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | |
| All a |
8 (7.5) |
14 (13) |
8 (53) |
14 (58) |
0 (0) |
0 (0) |
0 (0) |
0 (0) |
0 (0) |
0 (0) |
| Bowel b |
31 (29) |
32 (31) |
0 (0) |
0 (0) |
0 (0) |
0 (0) |
0 (0) |
0 (0) |
31 (51) |
32 (53) |
| Sex c |
7 (6.5) |
8 (7.7) |
0 (0) |
0 (0) |
5 (33) |
7 (54) |
2 (13) |
1 (14) |
0 (0) |
0 (0) |
| Bowel and Sex d |
0 (0) |
1 (1.0) |
0 (0) |
1 (4.2) |
0 (0) |
0 (0) |
0 (0) |
0 (0) |
0 (0) |
0 (0) |
| Bladder e |
1 (0.9) |
2 (1.9) |
1 (6.7) |
2 (8.3) |
0 (0) |
0 (0) |
0 (0) |
0 (0) |
0 (0) |
0 (0) |
| None f |
60 (56) |
47 (45) |
6 (40) |
7 (29) |
10 (67) |
6 (46) |
14 (88) |
6 (86) |
30 (49) |
28 (47) |
| p-value g | 0.29 | 0.05 | 0.65 | 0.97 | 0.71 | |||||
a. Concerned about bladder, sexual, and bowel dysfunction concordant with active surveillance.
b. Concerned about bowel dysfunction concordant with radical prostatectomy.
c. Concerned about sexual dysfunction concordant with external beam radiotherapy and brachytherapy.
d. Concerned about bowel and sex dysfunction concordant with active surveillance.
e. Concerned about bladder dysfunction concordant with active surveillance.
f. Not concerned about any influential side effects concordant with all treatment choices.
g. p-value to test difference in concordance between intervention and control group.